LEAP2 and obesity disorder: The author of [56] suggests that changes in the LEAP2/acyl-ghrelin ratio observed in obesity, specifically the rise in LEAP2 levels and the decrease in acyl ghrelin, may be key factors contributing to the development of ghrelin resistance in obese individuals.